Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Anifrolumab Shows Benefit in Patients with Systemic Lupus Erythematosus

americanpharmaceuticalreviewJune 04, 2021

Tag: Anifrolumab , Arthritis , skin rash

PharmaSources Customer Service